1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. ALLOGENE THERAPEUTICS INC
Allogene Therapeutics Inc XNAS: ALLO

Allogene Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

about

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-c...

Read More
1.70 0.06 (3.66%)
55.03% Fall from 52W High
4.6M
XNAS Volume

XNAS 14 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
Not Eligible
Valuation Score
Expensive Valuation
12.8 / 100
Momentum Score
Technically Moderately Bullish
69.8 / 100
Analyst Price Target
7
1Yr Price target upside is 334%
12 analysts

18

S

5

W

5

O

0

T

SWOT Analysis

Allogene Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..